SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS RISPERIDONA INYECTABLE, RILPIVIRINA...
1 fournisseur attributaire•31 lots attribués•37,54 M € attribués
Acheteur: Servicio Murciano de Salud / Espinardo, Spain
Valeur attribuée
37,54 M €
Valeur estimée
206,14 M €
Attribué à 18% de la valeur estimée
Date d'attribution
20 mars 2024
Lauréats
1
Lots attribués
31
Valeurs d'attribution
Total de l'avis
37,54 M €
Somme des lots
45,93 M €
Le total de l'avis TED et les valeurs par lot ne correspondent pas exactement.
Lauréats
MAD, ESP
37,5 M € Ce contrat
27 avis d’attribution•111 lots attribués•383,60 M € au total
Lots attribués
| Lot | Titre | Lauréat | Valeur | CPV principal |
|---|---|---|---|---|
| LOT-0031 | JANSSEN CILAG, S.A. | 8,6 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0012 | JANSSEN CILAG, S.A. | 6,4 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | Non précisé | 5,4 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | JANSSEN CILAG, S.A. | 5,0 M € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0013 | JANSSEN CILAG, S.A. | 2,8 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | JANSSEN CILAG, S.A. | 2,7 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | Non précisé | 2,7 M € | Other nervous system medicinal products (33661700) | |
| LOT-0025 | JANSSEN CILAG, S.A. | 2,6 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0030 | JANSSEN CILAG, S.A. | 1,5 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0020 | JANSSEN CILAG, S.A. | 1,2 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | JANSSEN CILAG, S.A. | 1,1 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0006 | JANSSEN CILAG, S.A. | 1,0 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0019 | JANSSEN CILAG, S.A. | 732 132 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0021 | JANSSEN CILAG, S.A. | 650 784 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | JANSSEN CILAG, S.A. | 592 740 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | JANSSEN CILAG, S.A. | 523 990 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0028 | JANSSEN CILAG, S.A. | 381 640 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | JANSSEN CILAG, S.A. | 366 656 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | JANSSEN CILAG, S.A. | 352 880 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | JANSSEN CILAG, S.A. | 271 160 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | Non précisé | 216 757 € | Antineoplastic and immunomodulating agents (33652000), Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | JANSSEN CILAG, S.A. | 135 580 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | JANSSEN CILAG, S.A. | 122 253 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | JANSSEN CILAG, S.A. | 106 926 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0029 | JANSSEN CILAG, S.A. | 95 740 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | JANSSEN CILAG, S.A. | 53 331 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | JANSSEN CILAG, S.A. | 52 399 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | JANSSEN CILAG, S.A. | 41 684 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0014 | JANSSEN CILAG, S.A. | 32 913 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | JANSSEN CILAG, S.A. | 17 644 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0033 | Non précisé | — | Psycholeptics (33661500) |